Correlation Between Iterum Therapeutics and Scopus Biopharma
Can any of the company-specific risk be diversified away by investing in both Iterum Therapeutics and Scopus Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iterum Therapeutics and Scopus Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iterum Therapeutics PLC and Scopus Biopharma, you can compare the effects of market volatilities on Iterum Therapeutics and Scopus Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iterum Therapeutics with a short position of Scopus Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iterum Therapeutics and Scopus Biopharma.
Diversification Opportunities for Iterum Therapeutics and Scopus Biopharma
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Iterum and Scopus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Iterum Therapeutics PLC and Scopus Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scopus Biopharma and Iterum Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iterum Therapeutics PLC are associated (or correlated) with Scopus Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scopus Biopharma has no effect on the direction of Iterum Therapeutics i.e., Iterum Therapeutics and Scopus Biopharma go up and down completely randomly.
Pair Corralation between Iterum Therapeutics and Scopus Biopharma
If you would invest (100.00) in Scopus Biopharma on December 28, 2024 and sell it today you would earn a total of 100.00 from holding Scopus Biopharma or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Iterum Therapeutics PLC vs. Scopus Biopharma
Performance |
Timeline |
Iterum Therapeutics PLC |
Scopus Biopharma |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Iterum Therapeutics and Scopus Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Iterum Therapeutics and Scopus Biopharma
The main advantage of trading using opposite Iterum Therapeutics and Scopus Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iterum Therapeutics position performs unexpectedly, Scopus Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scopus Biopharma will offset losses from the drop in Scopus Biopharma's long position.Iterum Therapeutics vs. Adial Pharmaceuticals | Iterum Therapeutics vs. Tonix Pharmaceuticals Holding | Iterum Therapeutics vs. Fortress Biotech | Iterum Therapeutics vs. Eyenovia |
Scopus Biopharma vs. Scpharmaceuticals | Scopus Biopharma vs. DiaMedica Therapeutics | Scopus Biopharma vs. Monopar Therapeutics | Scopus Biopharma vs. Pasithea Therapeutics Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |